Veterinary medicines highlights 2021EMA has published an overview of its key recommendations of 2021 regarding the authorisation and safety monitoring of veterinary medicines.
In 2021, EMA recommended 12 medicines for marketing authorisation. Of these, seven had a new active substance. Five are vaccines, including four new biotechnological vaccines.
A selection of these recommendations can be found in the veterinary medicines highlights document published today.